Tissue kallikrein protects cortical neurons against hypoxia/reoxygenation injury via the ERK1/2 pathway

Biochemical and Biophysical Research Communications

Volumn 407, Issue 2, 2011, Pages 283-287

  Liu, Ling ^a,b   Liu, Haibo ^c   Yang, Fang ^a   Chen, Guanghui ^a   Zhou, Houguang ^b   Tang, Min ^d   Zhang, Renliang ^a   Dong, Qiang ^b,e  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Air Force Command of Nanjing ^*  (China)

^d ZHEJIANG UNIVERSITY   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Bradykinin B2 receptor; Hypoxia reoxygenation; Neuron; Tissue kallikrein

Indexed keywords

BRADYKININ B2 RECEPTOR; ICATIBANT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TISSUE KALLIKREIN;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN HYPOXIA; BRAIN INJURY; CELL HYPOXIA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; ENZYME ANALYSIS; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION;

ANIMALS; BRADYKININ; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL CORTEX; CYTOPROTECTION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; RATS; RECEPTORS, BRADYKININ; REPERFUSION INJURY; TISSUE KALLIKREINS;

EID: 79953678351     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.112     Document Type: Article

References (25)

1. Couture R., Harrisson M., Vianna R.M., Cloutier F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 2001, 429:161-176.
2. Chao J., Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Exp. Physiol. 2005, 90:291-298.
3. Emanuelia C., Madeddu P. Human tissue kallikrein: a new bullet for the treatment of ischemia. Curr. Pharm. Des. 2003, 9:589-597.
4. Walker K., Perkins M., Dray A. Kinins and kinin receptors in the nervous system. Neurochem. Int. 1995, 26:1-16.
5. Wagner S., Kalb P., Lukosava M., Hilgenfeldt U., Schwaninger M. Activation of the tissue kallikrein-kinin system in stroke. J. Neurol. Sci. 2002, 202:75-76.
6. Xia C.F., Yin H., Borlongan C.V., Chao L., Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 2004, 43:452-459.
7. Xia C.F., Yin H., Yao Y.Y., Borlongan C.V., Chao L., Chao J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum. Gene Ther. 2006, 17:206-219.
8. Liu L., Zhang R., Liu K., Zhou H., Tang Y., Su J., Yu X., Yang X., Tang M., Dong Q. Tissue kallikrein alleviates glutamate-induced neurotoxicity by activating ERK1. J. Neurosci. Res. 2009, 87:3576-3590.
9. Liu L., Zhang R., Liu K., Zhou H., Yang X., Liu X., Tang M., Su J., Dong Q. Tissue kallikrein protects cortical neurons against in vitro ischemia-acidosis/reperfusion-induced injury through the ERK1/2 pathway. Exp. Neurol. 2009, 219:453-465.
10. Tang M., Cui M., Dong Q., Ren H.M., Xiao B.G., Luo B.Y., Shao Y., Liu L., Zhou H.G. The bradykinin B2 receptor mediates hypoxia/reoxygenation induced neuronal cell apoptosis through the ERK1/2 pathway. Neurosci. Lett. 2009, 450:40-44.
11. Yasuyoshi H., Kashii S., Zhang S., Nishida A., Yamauchi T., Honda Y., Asano Y., Sato S., Akaike A. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons. Invest. Ophthalmol. Vis. Sci. 2000, 41:2273-2278.
12. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 1993, 35:567-576.
13. Xiong Z.G., Zhu X.M., Chu X.P., Minami M., Hey J., Wei W.L., MacDonald J.F., Wemmie J.A., Price M.P., Welsh M.J., Simon R.P. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 2004, 118:687-698.
14. Chao J., Shen B., Gao L., Xia C.F., Bledsoe G., Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biol. Chem. 2010, 391:345-355.
15. Yao Y.Y., Yin H., Shen B., Smith R.S., Liu Y., Gao L., Chao L., Chao J. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Cardiovasc. Res. 2008, 80:354-364.
16. Yuan G., Deng J., Wang T., Zhao C., Xu X., Wang P., Voltz J.W., Edin M.L., Xiao X., Chao L., Chao J., Zhang X.A., Zeldin D.C., Wang D.W. Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5′-monophosphate-activated protein kinase signaling pathways. Endocrinology 2007, 148:2016-2026.
17. Xia C.F., Smith R.S., Shen B., Yang Z.R., Borlongan C.V., Chao L., Chao J. Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension 2006, 47:752-761.
18. Adolfo A.G., Regina P.S., Cristina L.E., Bader M., Abrao C.E., da G.N.-M., Pesquero J.B., Antonio S.J. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy. Brain Res. 2004, 1013:30-39.
19. Kakoki M., McGarrah R.W., Kim H.S., Smithies O. Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 2007, 104:7576-7581.
20. Su J., Cui M., Tang Y., Zhou H., Liu L., Dong Q. Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition. Biochem. Biophys. Res. Commun. 2009, 388:205-211.
21. Chiang W.C., Chien C.T., Lin W.W., Lin S.L., Chen Y.M., Lai C.F., Wu K.D., Chao J., Tsai T.J. Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury. Free Radic. Biol. Med. 2006, 41:1304-1314.
22. Zausinger S., Lumenta D.B., Pruneau D., Schmid-Elsaesser R., Plesnila N., Baethmann A. Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia. Brain Res. 2002, 950:268-278.
23. Roux P.P., Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 2004, 68:320-344.
24. Shackelford D.A., Yeh R.Y. Modulation of ERK and JNK activity by transient forebrain ischemia in rats. J. Neurosci. Res. 2006, 83:476-488.
25. Irving E.A., Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. J. Cereb. Blood Flow Metab. 2002, 22:631-647.